THE DEAL, AT A GLANCE

Aqua Medical

2/4 reviewed

Aqua Medical

Aqua Medical develops a scope-delivered vapor treatment being studied for Type 2 diabetes.

Aqua Medical raised $589M Series B, announced 2026-09-25

01What it doesAqua Medical develops a scope-delivered vapor treatment being studied for Type 2 diabetes.Source-grounded · automated review · Explore ↗

Checked 2026-10-03 · Review due 2026-10-10

Read supporting source ↗

Aqua Medical is a clinical-stage…

02Who is involvedBacked by Relevance VenturesFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗

03What happenedAqua Medical raised $589M Series B, announced 2026-09-25From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗

04Why it mattersThe funding helps move its diabetes procedure from pilot testing toward a larger U.S. clinical trial.Interpretation · Explore ↗

Checked 2026-10-03 · Review due 2026-10-10

Read supporting source ↗

Capital from the financing will…

Click a part to explore its evidence. The image is supplied by the cited source.Original record source ↗

Aqua Medical · Financing Record

Explore source-linked visual explanations for Aqua Medical. Unsupported claims are withheld while source review continues.

Record 12760 · Recorded date: 2026-09-25